Advanced Oncotherapy (AVO) Share Price, News & Analysis

Company Overview

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 1.75 to 1.75
• 52-Week Range: N/A
• Volume: 200,000 shs
• Average Volume: 1.27 million shs
• Market Capitalization: £9.50 million
• P/E Ratio: N/A
• Dividend Yield: 5.49%
• Price Target: N/A
• Consensus Rating: N/A

AVO Stock Analysis - Frequently Asked Questions

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) announced its earnings results on Monday, June, 29th. The company reported ($9.83) EPS for the quarter, missing the consensus estimate of ($8.90) by $0.93.

How do I buy shares of Advanced Oncotherapy?

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Academy Sports and Outdoors (ASO), Renishaw (RSW), Tullow Oil (TLW), BMR Group (BMR), Lancashire (LRE) and Sirius Minerals (SXX).

Company Calendar

• Last Earnings: 6/29/2020
• Today: 8/01/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Agriculture
• Current Symbol: LON:AVO
• CIK: N/A
• Web: www.advancedoncotherapy.com
• Phone: +44-20-36178728
• Fax: N/A
• Employees: 3,900
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£32.60 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -67.34%
• Return on Assets: -11.73%

Debt

• Debt-to-Equity Ratio: 98.71
• Current Ratio: 1.26
• Quick Ratio: 0.13

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: 33.50
• Book Value: GBX 14 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 542,570,000
• Free Float: N/A
• Market Cap: £9.50 million
• Optionable: Not Optionable
• Beta: 0.06